| Literature DB >> 28439408 |
Aina Gomila1,2, Jordi Carratalà1,2,3, Daniel Camprubí1,2, Evelyn Shaw1,2, Josep Mª Badia2,4, Antoni Cruz2,5, Francesc Aguilar2,6, Carmen Nicolás2,7, Anna Marrón2,8, Laura Mora2,9, Rafel Perez2,10, Lydia Martin2,11, Rosa Vázquez2,4, Ana Felisa Lopez2,12, Enric Limón2,3, Francesc Gudiol2,3, Miquel Pujol1,2,13.
Abstract
BACKGROUND: Organ-space surgical site infections (SSI) are the most serious and costly infections after colorectal surgery. Most previous studies of risk factors for SSI have analysed colon and rectal procedures together. The aim of the study was to determine whether colon and rectal procedures have different risk factors and outcomes for organ-space SSI.Entities:
Keywords: Colorectal surgery; Organ-space surgical site infections; Surgical site infections; Surveillance
Year: 2017 PMID: 28439408 PMCID: PMC5401556 DOI: 10.1186/s13756-017-0198-8
Source DB: PubMed Journal: Antimicrob Resist Infect Control ISSN: 2047-2994 Impact factor: 4.887
Characteristics of patients in colon and rectal surgery
| Variable | Colon ( | Rectum ( |
|
|---|---|---|---|
| Age, median (IQR) years | 70.6 (62–79) | 68 (60–76) | <0.001 |
| Age ≥65, | 1711 (67.95%) | 724 (61.20%) | 0.001 |
| Males, | 1494 (59.33%) | 795 (67.20%) | 0.001 |
| ASA III-IV, | 1062 (42.18%) | 434 (36.69%) | 0.002 |
| Neoplasia, | 2355 (93.5%) | 1147 (97%) | <0.001 |
| Inflammatory bowel disease, | 75 (3%) | 16 (1.4%) | 0.003 |
| Other, | 86 (3.4%) | 17 (1.4%) | 0.001 |
| Duration of surgery ≥75th-percentilea, | 947 (37.61%) | 505 (42.69%) | 0.003 |
| NNIS Risk index 1–2, | 909 (36.10%) | 398 (33.64%) | 0.15 |
| Laparoscopy, | 1515 (60.17%) | 782 (66.10%) | 0.001 |
| Correct IV antibiotic prophylaxis, | 2117 (84.07%) | 966 (81.66%) | 0.41 |
| Previous radiotherapy, | 33 (1.31%) | 545 (46.07%) | <0.001 |
| Previous chemotherapy, | 78 (3.10%) | 533 (45.05%) | <0.001 |
| Oral antibiotic prophylaxis, | 1078 (42.81%) | 489 (41.34%) | 0.41 |
| Mechanical bowel preparation, | 1749 (69.46%) | 1038 (87.74%) | <0.001 |
| - Missing | 58 (2.30%) | 20 (1.69%) | |
| Ostomy, | 208 (8.26%) | 754 (63.74%) | <0.001 |
IQR interquartile range, ASA American Society of Anesthesiologists physical status classification, NNIS National Nosocomial Infections Surveillance, IV intravenous
aGreater than 75th percentile for the duration of surgery (180 min, 3 h)
Fig. 1Incidence of surgical site infection in colon and rectal surgery. Shows the incidence of overall surgical site infection, incisional surgical site infection and organ-space surgical site infection in colon and rectal surgery separately. SSI: surgical site infection
Univariate analysis of risk factors for organ-space surgical site infection in colon and rectal surgery
| Colon | Rectum | |||||
|---|---|---|---|---|---|---|
| Risk factor | No OS-SSI ( | OS-SSI ( |
| No OS-SSI ( | OS-SSI ( |
|
| Age, median (IQR) years | 70 (61–79) | 73 (63–79) | 0.3 | 68 (60–76) | 66.5 (58–74) | 0.07 |
| Age ≥ 65 years, (%) | 67.6 | 72 | 0.2 | 61.5 | 58.8 | 0.5 |
| Male sex, (%) | 58.4 | 70 | 0.001 | 65.4 | 80.9 | <0.001 |
| ASA ≥ III, (%) | 41.9 | 45.5 | 0.3 | 36.1 | 41.2 | 0.25 |
| Correct IV antibiotic prophylaxis, (%) | 84.3 | 81.5 | 0.3 | 81.4 | 83.8 | 0.5 |
| Duration of operation ≥ p75tha, (%) | 37.5 | 39 | 0.7 | 41.2 | 54.4 | 0.003 |
| Laparoscopy, (%) | 61.6 | 44 | <0.001 | 66.3 | 64.7 | 0.7 |
| NNIS ≥ 1, (%) | 35.5 | 43 | 0.03 | 32.7 | 41.2 | 0.05 |
| Neoplasia, (%) | 93.6 | 93 | 0.7 | 97.2 | 94.9 | 0.13 |
| Inflammatory bowel disease, (%) | 2.9 | 4 | 0.38 | 1.1 | 2.9 | 0.1 |
| Chemotherapy, (%) | 3.1 | 3.5 | 0.7 | 45.1 | 45.2 | 1 |
| Radiotherapy, (%) | 1.2 | 2.5 | 0.18 | 46 | 47.4 | 0.7 |
| Oral antibiotic prophylaxis, (%) | 43.7 | 33 | 0.004 | 43.3 | 26.5 | <0.001 |
| Mechanical bowel preparation, (%) | 71.4 | 67.2 | 0.2 | 89.1 | 90.4 | 0.6 |
| Ostomy, (%) | 7.3 | 20 | <0.001 | 63.8 | 65.2 | 0.7 |
No OS-SSI no organ-space surgical site infections (include patients with incisional SSI and patients without SSI), OS-SSI organ-space SSI, IQR interquartile range, ASA American Society of Anesthesiologists physical status classification, IV intravenous, NNIS National Nosocomial Infections Surveillance Risk Index.
aGreater than 75th percentile for the duration of surgery (180 min, 3 h)
Multivariate analysis of risk factors for organ-space surgical site infection in colon and rectal surgery
| Colon | Rectum | ||||||
|---|---|---|---|---|---|---|---|
| Risk factor | OR | 95% CI |
| Risk factor | OR | 95% CI |
|
| Male sex |
|
|
| Male sex |
|
|
|
| Laparoscopy |
|
|
| Duration of operation ≥ p75tha |
|
|
|
| NNIS ≥ 1 | 1.17 | 0.83–1.64 | 0.36 | NNIS ≥ 1 | 1.1 | 0.74–1.66 | 0.6 |
| Oral antibiotic prophylaxis |
|
|
| Oral antibiotic prophylaxis |
|
|
|
| Ostomy |
|
|
| ||||
Signifficant OR and 95% CI appear in bold text
OR Odds ratio, 95%CI 95% confidence interval, NNIS National Nosocomial Infections Surveillance Risk Index.
aGreater than 75th percentile for the duration of surgery (180 min, 3 h)
Outcomes of patients with organ-space surgical site infection in colon and rectal surgery
| Variable | Colon ( | Rectum ( | Overall ( |
|
|---|---|---|---|---|
| Readmission, | 39 (19.5) | 33 (24.3) | 72 (21.4) | 0.3 |
| Readmission due to SSI, | 34 (17) | 30 (22.1) | 64 (19) | 0.2 |
| Length of stay, median (IQR) days | 25 (18–31) | 23 (16–33) | 24 (17–36) | 0.1 |
| Length of stay, mean (SD) days | 30.2 (25) | 32 (28) | 27.6 (19.7) | 0.1 |
| Mortality, | 23 (11.5) | 7 (5.1) | 30 (8.9) | 0.04 |
| Mortality attributed to SSI, | 21 (10.5) | 6 (4.4) | 27 (8) | 0.04 |
SSI surgical site infection, IQR interquartile range, SD standard deviation